Taurine analogues and taurine transport: Therapeutic advantages

Advances in Experimental Medicine and Biology

Volumn 583, Issue , 2006, Pages 449-467

  Gupta, R C ^a  

^a NAGALAND UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934438236     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33504-9_52     Document Type: Conference Paper

References (42)

1. Champseix, A., Chanet-Ray, J., Etienne, A., LeBerre, A.; Masson, J. C., Napierala, C.; and Vessiere, R., 1985, Synthese de β sultams (thiazetidenes-1,2 dioxide-1,1) R. Bull. Soc. Chim. Franc. 463-472.
2. Chauncey, K. B., Tenner, T. E., Lombardini, J. B., Jones, B. G., Brooks, M. L., Warner, R. D., Davis, R. L., and Ragain, R. M., 2003, The effect of taurine supplementation on patients with type 2 diabetes mellitus, Adv. Exp. Med. Biol. 526:91-96.
3. Covelo, M. and Simone, F., 1970, Nuovi iodoganici di sintesi, Soc. Nazional Sci. Lett. Art. (Napoli) 37:154-169.
4. Dawson, R., Jr., 2003, Taurine in ageing and models of neurodegeneration, Adv. Exp. Med. Biol. 23:537-545.
5. Della Corte, L., Crichton, R. R., Duburs, G., Nolan, K., Tipton, K. F., Tirzitis, G., and Ward, R. J., 2002, The use of taurine analogues to investigate taurine functions and their potential therapeutic applications, Amino Acids 23:367-379.
6. Desai, T. K., Maliakkal, J., Kinizie, J. L., Ehrinpreis, M. N., Luk, G. D., and Ceika, J., 1992, Taurine deficiency and intensive chemotherapy and or radiation, Am. J. Clin. Nutr. 55:708-711.
7. Evans, P. and Halliwell, B., 2001, Micronutrients: oxidant/antioxidant status, Br. J. Nutr. 85:S67.
8. Frosini, M., Sesti, C., Simona, S., Donati, A., Palmi, M., Valoti, M., Machetti, F., and Sgaragli, G., 2000, Effects of taurine and some some structurally related analogues on the central mechanism of thermoregulation. A structure-activity relationship study, Adv. Exp. Med. Biol. 483:273-282.
9. Gupta, R. C. and Kim, S. J., 2003a, A role of taurine in organ dysfunction and in their alleviation, Crit. Care Shock 6:171-179.
10. Gupta, R. C. and Kim, S. J., 2003b, Taurine, analogues and bone: a growing relationship, Adv. Exp. Med Biol. 526:323-328.
11. Gorohovsky, S., Temtsin-Krayz, G., and Bittner, S., 2003, Quinonyltaurine, Amino Acids, 24:281-288.
12. Huxtable, R. J., 1989, Taurine in the central nervous system and the mammalian actions of taurine, Prog. Neurobiol. 32:471-533.
13. Huxtable, R. J, Laird, H., and Lippincott, S. E., 1979, The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulfonate. J. Pharmacol. Exp. Ther. 211:465-471.
14. Ito, R., Uchiyama, T., Ohno, H., and Kohda, T., 1985, Proposal of cascade action of taurine related sulfur amino acids on cardic and vascular nerves: protection and therapy of injuries after tooth extraction in guineapigs, Prog. Clin. Biol. Res. 179:215-224.
15. Jacobsen, J. G. and Smith, L.H., 1968, Biochemistry and physiology of taurine and taurine derivatives, Physiol. Rev. 48:424-511.
16. Khnychenko, L. K., Bul'on, V. V., and Sapronov, N. S., 2001, Effect of a novel taurine derivative on various parameters of metabolism on experimental myocardial infarction, Eksp. Klin. Farmakol. 64:38-40.
17. Koyama, T., Kayahara, H., and Kozo, N., 2003, Synthesis of peptides and determination of their taste and agglutination activity, Peptide Sci. 40:199-202.
18. Laidlaw, S. A., Dietrich, M. F., Lamtenzan, M. P., Vargas, H. I., Block, J. B., and Kopple, J. D., 1989, Antimutagenic effects of taurine in bacterial assay system, Cancer Res. 49:6600-6604.
19. Liebowitz, S. M., Lombardini, J. B., and Allen, C. I., 1986, 2-Aminoethylmethylsulfone (AEMS): a potent stimulator of ATP-dependent calcium uptake, Eur. J. Pharmacol. 120:111-113.
20. Lindén, I.-B., Gothóni, G., Kontro, P., and Oja, S. S., 1983, Anticonvulsant activity of 2-phthalimidoethanesulfonamides: new derivatives of taurine, Neurochem Int. 5:319-324.
21. Lombardini, J. B., 1994, Effects of taurine analogues on the phosphorylation of a 44 Da protein present in a mitochondrial subfraction of the rat heart: partial characterization of 44 Da phosphoprotein. J. Mol. Cell Cardiol. 26:1675-1689.
22. Lombardini, J. B. and Liebowitz, S. M., 1990, Inhibitory and stimulatory effects of structural and conformational analogs of taurine on ATP-dependent calcium ion uptake in the rat retina: deductions concerning the conformation of taurine, Prog. Clin Biol. Res. 351:197-206.
23. Lombardini, J. B., and Props, C., 1997, Analogs of taurine as inhibitors of the phosphorylation of a protein present in a mitochondrial fraction of rat retina, Amino Acids 13:115-130.
24. Mandel, P., Gupta, R. C., Bourguignon, J. J., Wermuth, C. G., Molina,V., Gobaille, S., Ciesielski, L., and Simler, S., 1985, Effects of taurine and taurine analogues on aggressive behavior, Prog. Clin. Biol. Res. 179:449-458.
25. Molaparast-Saless, F., Nellis, S. H., and Liedkte, A. S., 1988, The effects of propionylcarnitine taurine on cardiac performance in aerobic and ischemic myocardium, J. Mol. Cell. Cardiol. 20:63-74.
26. Molineux, H., Schofield, R., and Testa, N. G., 1987, Hematopoitic effects of TCNU in mice, Cancer Treat. Rep. 71:837-841.
27. Mori, M., Ganwiler, B. A., and Gerber, U., 2002, β-Alanine and taurine as endogenous agonist at glycine receptors in rat hippocampus in vitro, J. Physiol. 539:191-200.
28. Nakagawa, K. and Huxtable, R. J., 1985, The anticonvulsant actions of two lipophilic taurine derivatives, Neurochem. Int. 7:819-824.
29. Oja, S. S., Kontro, P., Lindén, I.-B., and Gothóni, G., 1983, Anticonvulsant action of some 2-aminoethanesulfonic acid (taurine) derivatives, Eur. J. Pharmacol. 87:191-198.
30. Oliver, M. F., 2002, Interection between taurine and ethanol in the central nervous system, Amino Acids 23:345-357.
31. Pellicciari, R., Sergio, C., Natalini, B., Roda, A., Burnella, G., and Fini, A., 1985, Bile acids with cyclopropane containing side chain synthesis and properties of 3α,7β-dihydroethyl amide, J. Med. Chem. 28:239-242.
32. Petegnief, V., Lleu, P., Gupta, R. C., Bourguignon, J. J., and Rebel, G., 1995, Taurine analogues modulation of taurine uptake by two different mechanisms in cultured glial cells, Biochem. Pharmacol. 49:399-410.
33. Poikans, J., Tinzitis, G., Bisenieks, E., Uldrikis, J., Gurevich, V., Mikhailova, I., and Dubars, C., 1994, The derivatives of 2,6 dimethyl-1,4-dihydroisonicotinic acid and their antiplatelet properties, Eur. J. Med. Chem. 29:325-328.
34. Pokhrel, P. K. and Lau-Cam, C .A., 2000, In vitro and in vivo effects of taurine and structurally related sulfur-containing compounds against phenylhydrazine-inducd oxidative damage to erythrocytes, Adv. Exp. Med. Biol. 483:503-522.
35. Rebel, G., Petegnief, V., Lleu, P., Gupta, R. C., Guérin, P., and Bourguignon, J. 1994, New data on the regulation of taurine uptake in cultural nervous cells, Adv. Exp. Med. Biol. 359:225-233.
36. Reddy, B. S., Raoi, C. V., Rivenson, A., and Kelloff, G., 1993, Chemoprevention of colon carcinogenesis by organosulfur compounds, Cancer Res. 35:3493-3498.
37. Seidl, R., Peyrl, A., Nicham, R., and Hauser, E., 2000, A taurine and caffeine-containing drink stimulates cognitive performance and well-being, Amino Acids 19:635-642.
38. Sgaragli, G., Frosini, M., Palmi, M., Bianchi, L., and Della Corte, L., 1994, Calcium and taurine interaction in mammalian brain metabolism, Adv. Exp. Med. Biol. 359:299-308.
39. Trachtman, H., Del Pizzo, R., Sturman, J. A., Huxtable, R. J., and Finberg, L., H., 1988, Taurine and osmoregulation: administration of taurine analogs affords cerebral osmoprotection during chronic hypernatremic dehydration, Am. J. Dis. Child. 142:1194-1198.
40. Ward, R. J., Martinez, J., Ball, D., Marshall, E. J., and De Witte, P., 2000, Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: preliminary studies in chronic alcohol abusers, Adv. Exp. Med. Biol, 483:375-381.
41. Yan, C. C., Masella, R., Sun. Y., and Cotafora, A., 1991, Transport and function of taurine in mammalian cells and tissue, Estr. Acta Toxicol. Ther. 12:277-298.
42. Yarbrough, G. G.; Singh, D. K., and Taylor, D. A., 1981, Neuropharmacological characterization of a taurine antagonist, J. Pharmacol. Exp. Ther. 219:604-613.